SQ 14, 225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries

This publication has 11 references indexed in Scilit:

• Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients
  Annals of Internal Medicine, 1979
• Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent
  Progress in Cardiovascular Diseases, 1978
• Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
  Progress in Cardiovascular Diseases, 1978
• INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILURE
  The Lancet, 1978
• Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man
  New England Journal of Medicine, 1978
• Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits
  European Journal of Pharmacology, 1977
• Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension
  New England Journal of Medicine, 1977
• Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
  Science, 1977
• A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN
  The Lancet, 1977
• The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat
  The Journal of Physiology, 1965